HUTCHMED (China) Limited Sponsored ADR (HCM)
(Real Time Quote from BATS)
$18.83 USD
+0.67 (3.69%)
Updated Apr 29, 2024 02:57 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HCM 18.83 +0.67(3.69%)
Will HCM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCM
Wall Street Analysts See a 75.05% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?
After Plunging -10.7% in 4 Weeks, Here's Why the Trend Might Reverse for HUTCHMED (HCM)
HCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts See a 107.24% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?
Wall Street Analysts Think HUTCHMED (HCM) Could Surge 141.13%: Read This Before Placing a Bet
Wall Street Analysts See a 103.84% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?
Other News for HCM
UK shareholder meetings calendar - next 21 days
What's Driving HUTCHMED (China) Ltd's Surprising 38% Stock Rally?
HUTCHMED Nears EU Approval for Cancer Drug
Hutchmed notes CHMP's positive opinion for fruiquintinib approval
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda